To determine if the association was independent of TT, the model including VAT and HOMA-IR was run excluding TT, and the association of SHBG with lower NAFLD remained (OR, 0.50; 95% CI, 0.34–0.75). This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.